Altogether, our findings demonstrate thecritical roles of interleukin 33 in promoting colorectal cancer development throughinducing tumor-infiltrating ST2L+ regulatory T cells, and inhibition ofinterleukin-33/ST2L signaling maybe a potential target for the prevention of colorectalcancer. The gene discussed is IL33; the disease is colorectal cancer.